BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7616230)

  • 1. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain.
    Gong CX; Shaikh S; Wang JZ; Zaidi T; Grundke-Iqbal I; Iqbal K
    J Neurochem; 1995 Aug; 65(2):732-8. PubMed ID: 7616230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.
    Gong CX; Grundke-Iqbal I; Iqbal K
    Neuroscience; 1994 Aug; 61(4):765-72. PubMed ID: 7838376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoprotein phosphatase activities in Alzheimer disease brain.
    Gong CX; Singh TJ; Grundke-Iqbal I; Iqbal K
    J Neurochem; 1993 Sep; 61(3):921-7. PubMed ID: 8395566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin).
    Gong CX; Singh TJ; Grundke-Iqbal I; Iqbal K
    J Neurochem; 1994 Feb; 62(2):803-6. PubMed ID: 8294942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Brain Res Mol Brain Res; 1996 Jun; 38(2):200-8. PubMed ID: 8793108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5.
    Liu F; Zaidi T; Iqbal K; Grundke-Iqbal I; Gong CX
    Neuroscience; 2002; 115(3):829-37. PubMed ID: 12435421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of tau phosphorylation at different sites in Alzheimer disease brain.
    Ikura Y; Kudo T; Tanaka T; Tanii H; Grundke-Iqbal I; Iqbal K; Takeda M
    Neuroreport; 1998 Jul; 9(10):2375-9. PubMed ID: 9694231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease.
    Gong CX; Grundke-Iqbal I; Damuni Z; Iqbal K
    FEBS Lett; 1994 Mar; 341(1):94-8. PubMed ID: 8137929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
    Iqbal K; Alonso AD; Gondal JA; Gong CX; Haque N; Khatoon S; Sengupta A; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 2000; 59():213-22. PubMed ID: 10961432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics.
    Gong CX; Shaikh S; Grundke-Iqbal I; Iqbal K
    Brain Res; 1996 Nov; 741(1-2):95-102. PubMed ID: 9001710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease.
    Gong CX; Lidsky T; Wegiel J; Zuck L; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 2000 Feb; 275(8):5535-44. PubMed ID: 10681533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains.
    Pei JJ; Gong CX; Iqbal K; Grundke-Iqbal I; Wu QL; Winblad B; Cowburn RF
    J Neural Transm (Vienna); 1998; 105(1):69-83. PubMed ID: 9588762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A.
    Merrick SE; Demoise DC; Lee VM
    J Biol Chem; 1996 Mar; 271(10):5589-94. PubMed ID: 8621419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.
    Wang JZ; Gong CX; Zaidi T; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 1995 Mar; 270(9):4854-60. PubMed ID: 7876258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons.
    Burack MA; Halpain S
    Neuroscience; 1996 May; 72(1):167-84. PubMed ID: 8730715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.
    Bennecib M; Gong CX; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 2000 Nov; 485(1):87-93. PubMed ID: 11086171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury.
    Shultz SR; Wright DK; Zheng P; Stuchbery R; Liu SJ; Sashindranath M; Medcalf RL; Johnston LA; Hovens CM; Jones NC; O'Brien TJ
    Brain; 2015 May; 138(Pt 5):1297-313. PubMed ID: 25771151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.
    Planel E; Miyasaka T; Launey T; Chui DH; Tanemura K; Sato S; Murayama O; Ishiguro K; Tatebayashi Y; Takashima A
    J Neurosci; 2004 Mar; 24(10):2401-11. PubMed ID: 15014115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.